ATE186840T1 - Zusammensetzungen und methoden zur wundbehandlung - Google Patents
Zusammensetzungen und methoden zur wundbehandlungInfo
- Publication number
- ATE186840T1 ATE186840T1 AT92919722T AT92919722T ATE186840T1 AT E186840 T1 ATE186840 T1 AT E186840T1 AT 92919722 T AT92919722 T AT 92919722T AT 92919722 T AT92919722 T AT 92919722T AT E186840 T1 ATE186840 T1 AT E186840T1
- Authority
- AT
- Austria
- Prior art keywords
- formulations
- methods
- compositions
- wound treatment
- effective amount
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 4
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 102000009618 Transforming Growth Factors Human genes 0.000 abstract 1
- 108010009583 Transforming Growth Factors Proteins 0.000 abstract 1
- 239000003263 anabolic agent Substances 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Water Treatments (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75284991A | 1991-08-30 | 1991-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE186840T1 true ATE186840T1 (de) | 1999-12-15 |
Family
ID=25028127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92919722T ATE186840T1 (de) | 1991-08-30 | 1992-08-28 | Zusammensetzungen und methoden zur wundbehandlung |
Country Status (12)
Country | Link |
---|---|
US (1) | US5461030A (de) |
EP (1) | EP0650366B1 (de) |
JP (1) | JPH06510453A (de) |
AT (1) | ATE186840T1 (de) |
AU (1) | AU670413B2 (de) |
BR (1) | BR9206433A (de) |
CA (1) | CA2116549A1 (de) |
DE (1) | DE69230344T2 (de) |
FI (1) | FI940932A (de) |
HU (1) | HUT67319A (de) |
IL (1) | IL101229A0 (de) |
WO (1) | WO1993004691A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705485A (en) * | 1987-09-18 | 1998-01-06 | Ethicon, Inc. | Gel formulations containing growth factors |
US5591709A (en) * | 1991-08-30 | 1997-01-07 | Life Medical Sciences, Inc. | Compositions and methods for treating wounds |
US20020091155A1 (en) * | 1995-06-22 | 2002-07-11 | Btg Pharmaceutical Corp. | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
US5449522A (en) * | 1993-08-24 | 1995-09-12 | Hill; Albert F. | Pharmaceutical composition for immunoenhancement therapy |
US5840770A (en) * | 1993-08-24 | 1998-11-24 | Hill Medical Corporation | Method of killing tumor cells |
AUPM678294A0 (en) * | 1994-07-13 | 1994-08-04 | Gropep Pty Ltd | Use of insulin-like growth factor in combination with insulin |
ATE198039T1 (de) * | 1995-01-09 | 2000-12-15 | Thorel Jean Noel | Nährstoff für epidermale zellkultur und verwendung |
US5681561A (en) * | 1995-06-07 | 1997-10-28 | Life Medical Sciences, Inc. | Compositions and methods for improving autologous fat grafting |
US6380255B1 (en) * | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
EP1486565B1 (de) | 1995-10-11 | 2007-11-21 | Novartis Vaccines and Diagnostics, Inc. | Kombinierung von PDGF, KGF, IGF und IGFBP für Wundheilung |
US5783556A (en) * | 1996-08-13 | 1998-07-21 | Genentech, Inc. | Formulated insulin-containing composition |
US6692961B1 (en) * | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
ATE356198T1 (de) * | 1996-10-11 | 2007-03-15 | Invitrogen Corp | Definierte systeme zur kultivieurng epithelialer zellen und anwendung derselben |
US6576659B1 (en) * | 1996-12-05 | 2003-06-10 | Bio-Technology General Corp. | Use of oxandrolone in the treatment of burns an other wounds |
US5866546A (en) * | 1997-04-18 | 1999-02-02 | Hadasit Medical Research Services And Development Company Ltd. | Treatment for diabetes |
US6129817A (en) * | 1997-07-10 | 2000-10-10 | Westvaco Corporation | Unified on-line/off-line paper web formation analyzer |
DE19821625C1 (de) * | 1998-05-15 | 2000-01-05 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
GB9906715D0 (en) * | 1999-03-23 | 1999-05-19 | Ferring Bv | Compositions for promoting growth |
GB2362100B (en) | 2000-05-08 | 2002-05-08 | Maelor Pharmaceuticals Ltd | Wound gels |
KR100385293B1 (ko) * | 2000-05-13 | 2003-05-23 | 주식회사 리젠 바이오텍 | βig-h3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법 |
US7081240B1 (en) * | 2000-06-28 | 2006-07-25 | Zimmer Orthobiologics, Inc. | Protein mixtures for wound healing |
US20100129332A1 (en) * | 2000-07-31 | 2010-05-27 | Tamar Tennenbaum | Methods and pharmaceutical compositions for healing wounds |
US20030148924A1 (en) * | 2002-07-09 | 2003-08-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions of healing wounds |
US20040037828A1 (en) * | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
AU2001284364B2 (en) * | 2000-07-31 | 2006-09-28 | Bar Ilan University | Methods and pharmaceutical compositions for healing wounds |
US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
GB2369572A (en) * | 2000-11-29 | 2002-06-05 | Raft Trustees Ltd | Wound treatment composition comprising insulin |
US7115563B2 (en) * | 2002-05-29 | 2006-10-03 | Insignion Holding Limited | Composition and its therapeutic use |
GB0212405D0 (en) * | 2002-05-29 | 2002-07-10 | Insignion Holdings Ltd | Composition and its therapeutic use |
EP2340856B2 (de) * | 2003-05-24 | 2017-11-15 | La Prairie Group AG | Kosmetische oder dermatologische Zubereitung umfassend eine Nährmedienphase |
WO2005013885A2 (en) * | 2003-08-07 | 2005-02-17 | Healor Ltd. | Pharmaceutical compositions and methods for accelerating wound healing |
MXPA06011029A (es) * | 2004-04-07 | 2007-01-25 | Ares Trading Sa | Formulacion liquida de hormona del crecimiento. |
US7312198B2 (en) * | 2005-07-12 | 2007-12-25 | Essential Skincare, Llc | Protein compositions for promoting wound healing and skin regeneration |
WO2007026356A2 (en) | 2005-08-29 | 2007-03-08 | Healor Ltd. | Methods and compositions for prevention and treatment of diabetic and aged skin |
US7718170B2 (en) * | 2006-08-21 | 2010-05-18 | Essential Skincare, Llc | Alkaline phosphatase compositions to reduce skin cancer |
US20080098491A1 (en) * | 2006-10-19 | 2008-04-24 | Zoltan Laboratories Llc | Mouse models to study cachexia |
FR2907683A1 (fr) * | 2006-10-27 | 2008-05-02 | De Potter Philippe Viseux | Composition medicale pour cicatrisation des plaies et pansements permettant son application |
KR20100040912A (ko) * | 2007-07-30 | 2010-04-21 | 힐로 리미티드 | 약제학적 조성물 및 관련 방법 |
EP2234653B1 (de) | 2008-01-17 | 2014-07-30 | First Water Limited | Hydrogel-copolymer-zusammensetzung und verwendungen davon, z. b. als wundverband |
KR20130095835A (ko) * | 2009-02-24 | 2013-08-28 | 힐로 리미티드 | 여드름 및 기타 질환 치료용 비스파틴 치료제 |
GB0905290D0 (en) | 2009-03-27 | 2009-05-13 | First Water Ltd | Multilayer compositions and dressings |
WO2011083483A2 (en) | 2010-01-11 | 2011-07-14 | Healor Ltd. | Method for treatment of inflammatory disease and disorder |
US9474685B2 (en) | 2011-09-28 | 2016-10-25 | Sure-Shot Medical Device Inc. | Apparatus for localized dermatological treatment |
WO2013187899A1 (en) * | 2012-06-14 | 2013-12-19 | Ella Lindenbaum | Compositions and methods for stimulating wound healing |
US11432990B2 (en) | 2013-08-30 | 2022-09-06 | ISOS Solutions, LLC | Textured apparatus with therapeutic material incorporated therein and methods of manufacturing same |
GB201318842D0 (en) | 2013-10-24 | 2013-12-11 | First Water Ltd | Flexible hydrogel wound dressings |
US20220111111A1 (en) | 2019-01-17 | 2022-04-14 | Scapa Tapes Na | Composition for use in wound dressings |
IT201900022803A1 (it) * | 2019-12-03 | 2021-06-03 | Univ Degli Studi Di Ferrara | Gel di alginato per la medicazione di ferite cutanee |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3664925A (en) * | 1970-02-20 | 1972-05-23 | Martin Sonenberg | Clinically active bovine growth hormone fraction |
US3904753A (en) * | 1970-02-20 | 1975-09-09 | Research Corp | Clinically active bovine growth hormone fraction |
US4342832A (en) * | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
HU195618B (en) * | 1981-03-17 | 1988-06-28 | Human Oltoanyagtermelo | Process for producing composition for treating epidermic lesions of skin |
US4863899A (en) * | 1983-05-09 | 1989-09-05 | Todaro George J | Biologically active polypeptides |
US4444760A (en) * | 1983-06-17 | 1984-04-24 | Merck & Co., Inc. | Purification and characterization of a protein fibroblast growth factor |
US4673649A (en) * | 1983-07-15 | 1987-06-16 | University Patents, Inc. | Process and defined medium for growth of human epidermal keratinocyte cells |
US4940666A (en) * | 1983-07-15 | 1990-07-10 | University Patents, Inc. | Process and defined medium for growth of human epidermal keratinocyte cells |
US5165938A (en) * | 1984-11-29 | 1992-11-24 | Regents Of The University Of Minnesota | Wound healing agents derived from platelets |
US4696917A (en) * | 1985-08-01 | 1987-09-29 | Lindstrom Richard L | Irrigation solution |
US4886786A (en) * | 1985-08-01 | 1989-12-12 | Lindstrom Richard L | Additive for irrigation solution or surgical solution |
NZ226170A (en) * | 1987-09-18 | 1990-07-26 | Ethicon Inc | Stable freeze-dried pharmaceutical composition containing epidermal growth factor |
US5034375A (en) * | 1988-08-10 | 1991-07-23 | Institute Of Molecular Biology, Inc. | Process of wound healing using PDGF and EGF |
GB8823649D0 (en) * | 1988-10-07 | 1988-11-16 | Geistlich Soehne Ag | Chemical compounds |
US5036046A (en) * | 1988-10-12 | 1991-07-30 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
US5051443A (en) * | 1988-10-12 | 1991-09-24 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
US5013714A (en) * | 1988-12-15 | 1991-05-07 | Lindstrom Richard L | Viscoelastic solution |
US5204325A (en) * | 1988-12-15 | 1993-04-20 | Lindstrom Richard L | Viscoelastic solution |
US5218093A (en) * | 1989-03-01 | 1993-06-08 | Allelix Biopharmaceuticals, Inc. | EGF variants and pharmaceutical use thereof |
US5219739A (en) * | 1989-07-27 | 1993-06-15 | Scios Nova Inc. | DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121 |
US5035887A (en) * | 1989-09-07 | 1991-07-30 | Institute Of Moelcular Biology, Inc. | Wound healing composition of IL-1 and PDGF or IGF-1 |
US5056520A (en) * | 1989-10-11 | 1991-10-15 | Medex, Inc. | Probe for blood gas sensing |
EP0516901A1 (de) * | 1991-06-06 | 1992-12-09 | Richard L. Lindstrom | Methode und Einrichtung für serumlose medizinische Lösung |
-
1992
- 1992-02-28 HU HU9400593A patent/HUT67319A/hu unknown
- 1992-03-15 IL IL101229A patent/IL101229A0/xx unknown
- 1992-08-28 CA CA002116549A patent/CA2116549A1/en not_active Abandoned
- 1992-08-28 JP JP5505336A patent/JPH06510453A/ja active Pending
- 1992-08-28 AU AU25879/92A patent/AU670413B2/en not_active Ceased
- 1992-08-28 EP EP92919722A patent/EP0650366B1/de not_active Expired - Lifetime
- 1992-08-28 WO PCT/US1992/007341 patent/WO1993004691A1/en active IP Right Grant
- 1992-08-28 DE DE69230344T patent/DE69230344T2/de not_active Expired - Fee Related
- 1992-08-28 BR BR9206433A patent/BR9206433A/pt not_active Application Discontinuation
- 1992-08-28 AT AT92919722T patent/ATE186840T1/de not_active IP Right Cessation
-
1993
- 1993-11-29 US US08/158,808 patent/US5461030A/en not_active Expired - Fee Related
-
1994
- 1994-02-28 FI FI940932A patent/FI940932A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH06510453A (ja) | 1994-11-24 |
BR9206433A (pt) | 1994-09-27 |
CA2116549A1 (en) | 1993-03-18 |
US5461030A (en) | 1995-10-24 |
HUT67319A (en) | 1995-03-28 |
DE69230344T2 (de) | 2000-04-13 |
AU2587992A (en) | 1993-04-05 |
FI940932A0 (fi) | 1994-02-28 |
EP0650366B1 (de) | 1999-11-24 |
AU670413B2 (en) | 1996-07-18 |
WO1993004691A1 (en) | 1993-03-18 |
HU9400593D0 (en) | 1994-05-30 |
DE69230344D1 (de) | 1999-12-30 |
FI940932A (fi) | 1994-02-28 |
EP0650366A4 (de) | 1994-12-20 |
IL101229A0 (en) | 1992-11-15 |
EP0650366A1 (de) | 1995-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE186840T1 (de) | Zusammensetzungen und methoden zur wundbehandlung | |
DE69231486T2 (de) | Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und -regenerierung | |
DE69429450D1 (de) | Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung | |
NZ227788A (en) | Peptide having growth hormone regulatory effects, and compositions | |
ATE188383T1 (de) | Mischungen zum schutz und regenierung von geweben | |
DE69535264D1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
KR890700033A (ko) | 외상치료 및 뼈 재생 | |
BR9906477A (pt) | Cicatrizante de feridas enriquecido com plaquetas aperfeiçoado | |
ATE55695T1 (de) | Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien. | |
DE69316013T2 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
DE69718469D1 (de) | Verbindungen mit wachtumshormon freisetzenden eigenschaften | |
ATE121296T1 (de) | Igf-i zur behandlung von nebeneffekten der steroidtherapie. | |
PT77019A (de) | Mittel zur behandlung von wunden | |
DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
ATE178206T1 (de) | Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie | |
ATE291918T1 (de) | Kombinationstherapie zur behandlung von tumoren | |
ATE275580T1 (de) | Verfahren zur induktion der herstellung von wachstumsfaktoren | |
DE69023006T2 (de) | Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen. | |
NO940406L (no) | Preparat og fremgangsmåte for behandling av sårskader | |
ATE178336T1 (de) | Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis | |
ATE163344T1 (de) | Zusammensetzungen zur behandlung von geernteter pflanzenmaterial | |
ATE121935T1 (de) | D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren. | |
ATE329613T1 (de) | Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas | |
DE69230943T2 (de) | Zellzyklus- Kontrollzusammensetzungen und Methoden diese zu benutzen. | |
UA15363A (uk) | Засіб для лікуваhhя відкритих пошкоджеhь |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |